286 related articles for article (PubMed ID: 12917331)
1. Of mice and MEN1: Insulinomas in a conditional mouse knockout.
Crabtree JS; Scacheri PC; Ward JM; McNally SR; Swain GP; Montagna C; Hager JH; Hanahan D; Edlund H; Magnuson MA; Garrett-Beal L; Burns AL; Ried T; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS
Mol Cell Biol; 2003 Sep; 23(17):6075-85. PubMed ID: 12917331
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
[TBL] [Abstract][Full Text] [Related]
3. Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues.
Biondi CA; Gartside MG; Waring P; Loffler KA; Stark MS; Magnuson MA; Kay GF; Hayward NK
Mol Cell Biol; 2004 Apr; 24(8):3125-31. PubMed ID: 15060136
[TBL] [Abstract][Full Text] [Related]
4. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.
Crabtree JS; Scacheri PC; Ward JM; Garrett-Beal L; Emmert-Buck MR; Edgemon KA; Lorang D; Libutti SK; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1118-23. PubMed ID: 11158604
[TBL] [Abstract][Full Text] [Related]
5. The Cell Death Inhibitor ARC Is Induced in a Tissue-Specific Manner by Deletion of the Tumor Suppressor Gene Men1, but Not Required for Tumor Development and Growth.
McKimpson WM; Yuan Z; Zheng M; Crabtree JS; Libutti SK; Kitsis RN
PLoS One; 2015; 10(12):e0145792. PubMed ID: 26709830
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
Scacheri PC; Kennedy AL; Chin K; Miller MT; Hodgson JG; Gray JW; Marx SJ; Spiegel AM; Collins FS
Cancer Res; 2004 Oct; 64(19):7039-44. PubMed ID: 15466197
[TBL] [Abstract][Full Text] [Related]
7. Analysis of p27(Kip1) expression in insulinomas developed in pancreatic beta-cell specific Men1 mutant mice.
Fontanière S; Casse H; Bertolino P; Zhang CX
Fam Cancer; 2006; 5(1):49-54. PubMed ID: 16528608
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic co-operation in beta-cell tumorigenesis.
Pelengaris S; Khan M
Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
[TBL] [Abstract][Full Text] [Related]
9. Multiple endocrine neoplasia type 1 deletion in pancreatic alpha-cells leads to development of insulinomas in mice.
Shen HC; Ylaya K; Pechhold K; Wilson A; Adem A; Hewitt SM; Libutti SK
Endocrinology; 2010 Aug; 151(8):4024-30. PubMed ID: 20555035
[TBL] [Abstract][Full Text] [Related]
10. MEN1 tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2.
Gillam MP; Nimbalkar D; Sun L; Christov K; Ray D; Kaldis P; Liu X; Kiyokawa H
Oncogene; 2015 Feb; 34(7):932-8. PubMed ID: 24531709
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice.
Bertolino P; Tong WM; Herrera PL; Casse H; Zhang CX; Wang ZQ
Cancer Res; 2003 Aug; 63(16):4836-41. PubMed ID: 12941803
[TBL] [Abstract][Full Text] [Related]
12. Lack of MEN1 gene mutations in 27 sporadic insulinomas.
Cupisti K; Höppner W; Dotzenrath C; Simon D; Berndt I; Röher HD; Goretzki PE
Eur J Clin Invest; 2000 Apr; 30(4):325-9. PubMed ID: 10759881
[TBL] [Abstract][Full Text] [Related]
13. Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development.
Lu J; Herrera PL; Carreira C; Bonnavion R; Seigne C; Calender A; Bertolino P; Zhang CX
Gastroenterology; 2010 May; 138(5):1954-65. PubMed ID: 20138042
[TBL] [Abstract][Full Text] [Related]
14. The embryonic transcription factor Hlxb9 is a menin interacting partner that controls pancreatic β-cell proliferation and the expression of insulin regulators.
Shi K; Parekh VI; Roy S; Desai SS; Agarwal SK
Endocr Relat Cancer; 2013 Feb; 20(1):111-22. PubMed ID: 23419452
[TBL] [Abstract][Full Text] [Related]
15. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1.
Loffler KA; Biondi CA; Gartside M; Waring P; Stark M; Serewko-Auret MM; Muller HK; Hayward NK; Kay GF
Int J Cancer; 2007 Jan; 120(2):259-67. PubMed ID: 17044021
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism.
Libutti SK; Crabtree JS; Lorang D; Burns AL; Mazzanti C; Hewitt SM; O'Connor S; Ward JM; Emmert-Buck MR; Remaley A; Miller M; Turner E; Alexander HR; Arnold A; Marx SJ; Collins FS; Spiegel AM
Cancer Res; 2003 Nov; 63(22):8022-8. PubMed ID: 14633735
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.
Modali SD; Parekh VI; Kebebew E; Agarwal SK
Mol Endocrinol; 2015 Feb; 29(2):224-37. PubMed ID: 25565142
[TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of parathyroid and pancreatic tumors in a patient with multiple endocrine neoplasia type 1 using whole-exome sequencing.
Kim BY; Park MH; Woo HM; Jo HY; Kim JH; Choi HJ; Koo SK
BMC Med Genet; 2017 Oct; 18(1):106. PubMed ID: 28969599
[TBL] [Abstract][Full Text] [Related]
19. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic and CGH studies of four neuroendocrine tumors and tumor-derived cell lines of a patient with multiple endocrine neoplasia type 1.
Sigl E; Behmel A; Henn T; Wirnsberger G; Weinhausl A; Kaserer K; Niederle B; Pfragner R
Int J Oncol; 1999 Jul; 15(1):41-51. PubMed ID: 10375592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
